Dr. Coleman is a graduate of the University of New Mexico School of Medicine. She completed her family practice residency at Wm. Beaumont Hospital, Troy and Royal Oak, MI, consistently ranked among the United States Top 100 Hospitals by US News and World Report. Her experience includes faculty appointments to a family practice residency and three medical schools, as well as Director of Women's and Children's Health Promotion Programs with the NE Texas Public Health District. Dr. Coleman is widely published on health, practice management, family and parenting. Her passions include the well-being and education of children and families.
Receiving the Diagnosis Surely it feels overwhelming to receive a diagnosis of Lewy body dementia (LBD). How do you keep putting one foot in front of the other? How do you take the next breath? Your world just shattered. All you see in your future is a black hole. You
Although there is not one single test available that can diagnose Alzheimer’s, researchers have discovered key biomarkers associated with this disease. However, not everyone who displays these brain markers will develop the “classic” dementia that others do. A recent study from The University of Texas Medical Branch at Galveston may
Unlike most diseases, there is not one test that can definitively diagnose Alzheimer’s disease. Although brain scans can help rule out other possible causes when abnormal symptoms develop, such as strokes or brain tumors, a single test, scan, or exam cannot detect whether or not a patient is living with
By 2050, experts believe that the number of Americans living with Alzheimer’s will reach 14 million. As research continues to focus on potential treatment options, understanding key risk factors is also critical. Of the possible risk factors, researchers have closely studied the impact of alcohol consumption. Some studies have shown that
There is no denying the importance of dialysis for patients living with potentially fatal kidney diseases. Being a life-saving treatment, this intervention allows patients to better manage their illnesses. As stated by the National Kidney Foundation, nearly 500,000 Americans currently rely on this treatment to survive. However, researchers are now